Given that IFITM3 is an ISG and that low-dose IFN-γ has been reported to induce MHC-I expression in SCLC cell lines [11], we examined whether IFN-γ stimulation also upregulates IFITM3 expression in SCLC. Here, IFITM3 is linked to small cell lung carcinoma.